Q2
Mold-Tek Packaging Limited
Revenue-12.8%
Net Profit-30.9%
OPM18.65%
P&L
Quarterly Standalone
Revenue
-12.8%209.76
Expenditure
-10.7%189.34
Net Profit
-30.9%15.48
NPM 7.37%-20.7%EPS ₹4.66-30.9%
vs Q1 FY26
Mold-Tek Packaging's Pharma Sales Surge by 45% in Q2, Net Sales Rise by 16.05% H1onH1
29 Oct 2025 · 29 Oct 2025, 02:48 pm
Summary
Mold-Tek Packaging's Pharma sales have shown a significant growth of 45% in Q2 over Q1 in 2026. The net sales have also increased by 16.05% H1onH1. The volume of sales has increased by 11.01% H1 on H1. The EBDITA for the period has increased by 22.72% H1 on H1.
Key Highlights
- 1
Pharma Sales grew by 45% in Q2 over Q1 in 2026
- 2
Sales Increased by 16.05% H1onH1
- 3
Sales Volume increased by 11.01% H1 on H1
- 4
EBDITA for the period increased by 22.72% H1 on H1
Management Comments
J
J.Lakshmana Rao
The text does not provide specific management comments.
Informational and educational content only. Not investment advice.